AMETEK INC
Ticker: AMEHealthcareMedical InstrumentsS&P 500The business
AMETEK, Inc. (NYSE: AME) operates as a leading global manufacturer of electronic instruments and electromechanical devices, serving customers across diverse industrial and commercial markets. The company maintains its corporate presence at www.ametek.com and operates through two primary reportable segments: Electronic Instruments and Electromechanical.
The Electronic Instruments segment represents the larger portion of AMETEK's business and encompasses a broad portfolio of products including process and analytical instruments, power and energy instruments, and test and measurement equipment. This segment serves customers in aerospace, defense, power generation, oil and gas, pharmaceutical, and industrial automation sectors. The Electromechanical segment manufactures specialty motors, pumps, precision motion control systems, and other electromechanical devices for applications in aerospace, defense, industrial, and commercial markets.
AMETEK maintains a global operational footprint with manufacturing facilities, distribution centers, and sales offices across North America, Europe, Asia, and other international regions. The company employs thousands of professionals worldwide and serves a diverse customer base ranging from original equipment manufacturers to end-users across multiple industries. The company's scale is reflected in its substantial annual revenues and significant installed base of products in the field.
The company has built competitive advantages through its focus on innovation, quality, and customer service. AMETEK invests substantially in research and development to advance its product offerings and maintain technological leadership. The company has pursued a disciplined acquisition strategy over its history, integrating complementary businesses that enhance its product portfolio and market reach while maintaining operational excellence.
AMETEK's business model emphasizes recurring revenue streams through both product sales and aftermarket services. The company's diversified customer base and geographic presence provide resilience across economic cycles, while its specialized focus on engineered solutions for demanding applications supports premium positioning and customer loyalty. The company's commitment to continuous improvement and operational efficiency supports sustainable profitability and shareholder value creation.
- Sector
- Healthcare
- Industry
- Medical Instruments
- HQ
- BERWYN, PA
- FY end
- 12-31
- CIK
- 1037868
- SIC
- 3823
Ownership
Who holds AMETEK INC — across funds, superinvestors and bonds · N-PORT 2026Q2 · 13F 2026-06-30
Top fund holders
| Fund | % of fund | Value |
|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VTI · VANGUARD INDEX FUNDS | 0.08% | $1.76B |
| VANGUARD 500 INDEX FUND VOO · VANGUARD INDEX FUNDS | 0.09% | $1.44B |
| VANGUARD MID-CAP INDEX FUND VO · VANGUARD INDEX FUNDS | 0.54% | $1.20B |
| iShares Core S&P 500 ETF IVV · iShares Trust | 0.09% | $762.71M |
| State Street(R) SPDR(R) S&P 500(R) ETF Trust SPY | 0.09% | $672.09M |
Superinvestors in AMETEK INC
Share of each manager's reported 13F portfolio.
Bonds held by funds
Funds report holding 1 issues of AMETEK INC's debt, $6.68M at fund-held market value — what funds hold, not the company's debt outstanding. Weighted-average coupon 0.00%, maturing 2026–2026.
| Issue | Coupon | Matures | Funds | Fund-held |
|---|---|---|---|---|
| AMETEK INC NEW CP 0% 06/25/2026 | 0.000% | 2026-06-25 | 1 | $6.68M |
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Fund ownership is a subset of institutional 13F ownership — the two describe overlapping populations and must not be added together.
Go deeper in your own AI
15 years of statements, narrative and filings — queryable over MCP.
Professionals can also use the built-in AI chat (subscription + your own Anthropic key).
15 years of AMETEK INC's financials
Income statement, balance sheet and cash flow across 15 years, every filing with its disclosures, and each number traceable to the filing it came from — free with an account, no card required.
Sign in free